In breast cancer, YBX1 not only initiates KLF5 (Kruppel-Like Factor 5) transcription but also recognizes 5mC-modified KLF5 mRNA to stabilize it, ultimately promoting tumor progression [160]. Here, KLF5 is linked to breast cancer.